A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC ...

The first few weeks of the new Trump administration have been chaotic for science policy. With so much happening, it can be ...

Robert F. Kennedy Jr. told the Senate Finance Committee that he is not anti-vaccine during his confirmation hearing for ...

The newest weight-loss drugs, Wegovy and Zepbound ... there are GLP-1 receptors in brain regions that regulate impulse control and reward. That’s how scientists believe these medications ...

Paul Hudson, CEO of Sanofi, said the pharmaceutical company uses AI to help recommend which drugs to move forward ... process because AI agents have no careers at stake. "The agent isn't wedded ...

Speaking at a panel in Davos on Tuesday, Hudson said Sanofi uses AI to recommend whether drugs should "pass through ... because the agent doesn't have a career at stake," Hudson said.

Sanofi's CEO said the pharma firm uses AI to help decide to move a drug to the next developmental phase. He said it's a "sobering" process because AI agents have no careers at stake. "The agent ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and for weight loss, may be linked with a reduced risk of substance use and neurocognitive disorders, a US study in people ...

Because GLP-1 drugs act on brain regions involved in reward and impulse control, he adds, they might help to reduce cravings for tobacco, alcohol, cannabis and opioids. But the study found risks ...

WASHINGTON, Jan 18 (Reuters) - President-elect Donald Trump is poised to seize greater control of the federal ... protections from an estimated 50,000 career federal employees, allowing their ...